In the Search for New Anticancer Drugs, III+ Phosphorylated Diaziridine Derivatives

Total Page:16

File Type:pdf, Size:1020Kb

In the Search for New Anticancer Drugs, III+ Phosphorylated Diaziridine Derivatives In the Search for New Anticancer Drugs, III+ Phosphorylated Diaziridine Derivatives George Sosnovsky* and Jan Lukszo Department of Chemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201, U.S.A. Z. Naturforsch. 38b, 884-894 (1983); received August 30/December 24, 1982 Phosphorylated Diaziridines, Synthesis, Anticancer Drugs, Leukemia P 388 Several N-diethoxyphosphoryl derivatives 7 of various diaziridines, and compounds 12, 15a, lob, 18 and 20, structurally related to TEPA (la) and spin labeled Thio-TEPA (lc) were synthesized. 0 Me 0 N-P(0Et)2 HC=NN-p(<]) o / NR ' • 11 f / 1 ? R-O-P-f N —C—R R X N—R CL N "2 Me Me 1 3 1 2 3 7: R . R = alkyl 12 15a: R = R =R =Me N-0 R2=H, alkyl 15b: R' = H,R2R3=-|CH2|5- Me Me In three cases, attempts to synthesize phosphorylated diaziridine derivatives resulted in rearrangements to give the corresponding phosphorylated hydrazone derivatives 11 h, Hi and 12. Me 0 CH = NN — P(0Et)j 11 h: x= H 11 i : x = ci 13C NMR spectroscopy was shown to be a valuable tool in distinguishing between the structures of diaziridine and hydrazone derivatives. The in vivo testing of five representa- tive compounds (7e, 12, 15a, 16 and 20) against murine lymphocytic leukemia P 388 showed a lack of antitumor activity of compounds 7e, 15 a, 16 and 20, and an activity of compound 12 as evidenced by a T/C value of 194 and a % ILS of 94, at a dose of 32 mg/kg. Introduction pounds, triethylenimine thiophosphoramide, Thio- In the past three decades, extensive studies [1-9] TEPA (lb, R = ethylenimine ring), has been used have been made in the search for new antineoplastic drugs containing the ethylenimine-(aziridine) moi- X ety. In particular, the phosphorus derivatives of P R type 1 a and 1 b containing two or three phosphorus- N-aziridine bonds, have been found to be effective alkylating anticancer agents [8, 10, 11]. It is pre- sumed [12, 13] that the alkylating reactions occur 1a : X = 0. R = or other groups at the nucleophilic centers of the heterobases of lb: X = S, R = £N, or other groups DNA causing cross linking and, thereby, the cessa- 1c: X =S, R = OR. tion of the replication of DNA. One of these com- + Part II: P. L. Gutierrez, M. Konieczny, and G. Sosnovsky, Z. Naturforsch. 36b, 1612 (1981). * Reprint requests to Professor Dr. G. Sosnovsky. ' Me 0340-5087/83/0700-0884/$ 01.00/0 Me G. Sosnovsky-J. Lukszo • In the Search for New Anticancer Drugs 885 clinically in the chemotherapy of certain cancers Results and Discussion [10]. Recently, it has been claimed [14-16] that As starting materials, several selected diaziridines nitroxyl labeled analogs of Thio-TEPA, such as 2 derived either from aldehydes or ketones were SL-O-TT (lc) [14, 15] and PAT-1 (Id) [16] have prepared by the reaction of hydroxylamine-O-sul- more desirable toxicological properties than the fonic acid with the corresponding ketone 5 or clinically used Thio-TEPA. aldimine 6 in the presence of either ammonia or the In contrast to the aziridines, the three-membered corresponding amine, following either the literature diaziridine ring system 2, containing two nitrogen procedures exactly [17, 30-33] or adapting a known atoms, was only scantily studied for possible anti- procedure [31, 34] to different starting materials, as cancer activity [17]. Although the diaziridine ring in the preparation of 2f and 2i. The N-phosphory- system was discovered only about two decades ago, the methods of preparation and the reactions of N-H diaziridines have been extensively explored [18-21]. \ H,N-0-S0,H H2N-Q-SO3H' c=o — f— <1 I . ,C=N-R' The diaziridine ring system can readily undergo R H2N-R' N—R H,N-R' C ring opening reactions either by an SN 1 mechanism 5 2 [22], involving carbonium ion intermediates (3), or 5a: R - i-Pr, R2 = R3 = Me 5b: R = R2 = R3 = Me 5c: R = H, R2R3 - —ICH2I5- H 5d: R = Me, R2R3 = —ICH2I5- NR © NR NR' 3 \ /i x \ R 6e: R = Et, R2 = Me, R = H V 6f: R = i-Pr, R2 = Et, R3 = H 2 ,2/ © \ / R NR' NH 6g: R = n-Bu, R2 - Et, R3 = H 6h: R = Me, R2 = Ph, R3 — H 6i: R = Me, R2 = p-Cl-C6H4, R3 = H 6j: R - C6HU, R2 - Ph, R3 — H by unspecified mechanisms, mediated by nucleo- philes, involving a reaction of the C-N-N group lated derivatives 7 were synthesized either by an [21], formed by ring opening of the diaziridine with adaptation of the Todd-Atherton method [35], i.e. a nucleophile. A series of such reactions, formally by the reaction of the appropriate diaziridine of the alkylation type, with reagents such as nitrones (2 a, e, f, g) with diethyl phosphite and carbon [23], enamines [24], cyclopropenone [25, 26], al- tetrachloride in the presence of triethylamine, or kynyl ketones [27], diphenyl ketene [28], and lead by the reaction of the diaziridine (2 e, g) with diethyl tetraacetate [29] have been reported. On the basis phosphorochloridate in the presence of triethyl- of such reactions, it is plausible to assume that the amine, similarly to the recently reported procedure diaziridines might be useful as alkylating antineo- [36], plastic agents. In 1967, Szantay et al. reported such a study [17]. Thus, three N-phosphorylated dia- 0 ziridine derivatives 4 were synthesized and tested (EtO)2PH/CCti/NEt3 ,N—P(0Et)2 2a,e.f,g (EtQ)2PCl/NEt3 4-R' n-Bu-N* .N-Bu-n 7a: R1 i-Pr, R2 = R3 = Me N —P—N 7e: R1 = Et, R2 = Me, R3 = H EtCH CHEt 71: R1 = i-Pr, R2 = Et, R3 = H 7g: R1 = n-Bu, R2 = Et, R3 — H A; R=Cl. OH, HNCOEt Both reactions gave the desired products 7 in com- in vitro against the Sarcoma 180 cells. The in vitro parable yields, however, compounds 7 prepared by results seemed to be encouraging [17]. However, the Todd-Atherton method seem to be of a better the lack of in vivo data, and difficulties which were quality, as evidenced by the fact that samples of 7 experienced in our laboratory in reproducing some prepared by the alternative method using diethyl of the results reported [17], prompted us to in- phosphorochloridate appeared to darken more ra- vestigate this class of compounds in greater detail. pidly on storage at 0 °C. Attempts to achieve the 886 G. Sosnovsky-J. Lukszo • In the Search for New Anticancer Drugs 886 Table I. Diethyl diaziridine -1-phosphonates 7 and diethyl-N1-benzylidene-N-methylhydrazinephosphonates 11. a 15 Com- Yield b.p. [°C/torr] Purity N25 Molecular M.S.: m/e I.R.e H NMR (CCl4)h pound [%] or m.p. [°C] [%] formula0 [M++l]d v [cm-1] ö [ppm] f 7a 38 74—79/0.04 1.4395 C10H23N2O3P 251 960, 1020, 1050, 0.93-1.51 (m, 18H), 250 1250, 2930 2.16-2.70 (m, 1H), 3.85-4.40 (m, 4H) 7c 69 79-81/0.12 94 1.4390 C8HI9N203P 223 970, 1030, 1260, 1.18 (t, 3H), (64) 76-78/0.10 96 1.4390 222 2980 1.35 (t, 6H), 1.61 (d, 3H), 2.23-2.75 (m, 2H), 2.83-3.48 (m, 1H), 3.91-4.50 (m, 4H) 7f 67 78-80/0.05 97 1.4393 C10H23N2O3P 251 950, 1010, 1040, 0.83-1.50 (m, 15H), 250 1240, 2950 1.55-2.11 (m, 3H), 2.53-3.10 (m, 1H), 3.73-4.33 (m, 4H) 7g 68 84-85/0.05 98 1.4405 C11H25N2O3P 265 960, 1020, 1250, 0.71-2.10 (m, 18H), (57) 88-89/0.07 93 1.4416 264 2920 2.36-2.78 (m, 2H), 2.81-3.56 (m, 1H), 3.78-4.38 (m, 4H) llh 44 50-51.5 C12H19N2O3P 271 970, 1010, 1140, 1.27 (t, 6H), 270 1250, 2950 3.16 (d, 3H), 3.66-4.30 (m, 4H), 7.03-7.58 (m, 6H) lli 30 94-95 Ci2Hi8ClN203Ps 305 960, 1010, 1140, 1.27 (t, 6H), 305 307 1250, 2950 3.16 (d, 3H), 3.66-4.30 (m, 4H), 7.03-7.58 (m, 5H) a Yields of products by Todd-Atherton method, except in ( ) which were obtained by using diethyl phosphoro- chloridate as described in the general procedure B; b by iodometric titration; c the microanalyses were in agreement with the calculated values: C ±0-36%, H ±0.21%, N ±0.40%; d chemical ionization applied; e compounds 7a, e, f and g analyzed neat, compounds 11 h and lli as KBr pellets; f no reaction with acidified solution of KI, in spite of confirmed diaziridine structure by 13CNMR; g for the chloroderivative lli, two characteristic peaks with intensity ratio of 3:1 was observed; h the appearance of dublets (3.16 ppm) for methyl protons [-N(CH3)-P] in 11 h and lli is attributed to phosphorus-hydrogen coupling. phosphorylation by the Todd-Atherton method for diaziridines derived from aromatic aldehydes. using an excess of a diaziridine as a hydrogen The reactions of Schiff bases 6 h and 6 i with hy- chloride acceptor failed, probably because of the droxylamine-O-sulfonic acid in the presence of a low basicity of diaziridines [37]. Products 7 were 40% aqueous methylamine solution following the purified by repeated vacuum distillations to con- literature procedure [34], for the preparation of 2h, stant boiling temperature at 0.04 to 0.12 torr.
Recommended publications
  • Synthesis of Monocyclic Diaziridines and Their Fused Derivatives
    Special Issue Reviews and Accounts ARKIVOC 2008 (i) 128-152 Synthesis of monocyclic diaziridines and their fused derivatives Nina N. Makhova,* Vera Yu. Petukhova, and Vladimir V. Kuznetsov N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47, Leninsky prosp., 119991 Moscow, Russian Federation E-mail: [email protected] Abstract Diaziridines and their fused analogues have a wide-range potential as a test subjects for theoretical and practical application. This review covers our investigations focused on the development of optimal methods for the synthesis of monocyclic and fused diaziridine derivatives. Several approaches to the preparation of monocyclic diaziridine derivatives were developed: (1) a synthesis of 3,3-di- and 1,3,3-trialkylmono- and α,ω-bis(diaziridin-1-yl)alkanes from ketoxime O-sulfonates and ammonia, and primary aliphatic amines, respectively, as well as of practically previously inaccessible 3-monoalkyldiaziridines from ammonium salts of aldoxime O-sulfonic acids and ammonia (2) a synthesis of diaziridines from carbonyl compounds, primary aliphatic amines, and aminating reagents in water (or a water–MeOH mixture) at controlled pH of the medium, as well as from carbonyl compounds, amines and N-chloroalkylamines in aprotic solvents in the presence of K2CO3, and (3) a synthesis of 1,2,3-trialkyldiaziridines from N- chloroalkylamines without carbonyl compounds in the presence of primary aliphatic amines at high pressure. As regards fused diaziridine derivatives, general and simple methods were developed to prepare four types of these structures: 1,5-diazabicyclo[3.1.0]hexanes, 1,6- diazabicyclo[4.1.0]heptanes, 1,3,5-triazabicyclo[3.1.0] hexanes, including the parent compound and 2,4-nonsubstituted structures, and 1,3,6-triazabicyclo[3.1.0]hexanes, the latter being previously unknown.
    [Show full text]
  • Recent Advances in Chemical Biology Using Benzophenones and Diazirines As Radical Precursors
    molecules Review Recent Advances in Chemical Biology Using Benzophenones and Diazirines as Radical Precursors 1,2, , 1,2, Muhammad Murtaza Hassan * y and Olasunkanmi O. Olaoye y 1 Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road North, Mississauga, ON L5L 1C6, Canada; [email protected] 2 Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada * Correspondence: [email protected]; Tel.: +1-905-569-4588 These authors contributed equally to this work. y Academic Editor: Edward Lee-Ruff Received: 18 April 2020; Accepted: 9 May 2020; Published: 13 May 2020 Abstract: The use of light-activated chemical probes to study biological interactions was first discovered in the 1960s, and has since found many applications in studying diseases and gaining deeper insight into various cellular mechanisms involving protein–protein, protein–nucleic acid, protein–ligand (drug, probe), and protein–co-factor interactions, among others. This technique, often referred to as photoaffinity labelling, uses radical precursors that react almost instantaneously to yield spatial and temporal information about the nature of the interaction and the interacting partner(s). This review focuses on the recent advances in chemical biology in the use of benzophenones and diazirines, two of the most commonly known light-activatable radical precursors, with a focus on the last three years, and is intended to provide a solid understanding of their chemical and biological principles and their applications. Keywords: photoaffinity labelling; benzophenone; diazirine; radical precursors; interactome; SABRE; hyperpolarizing agents; crosslinking; photochemistry 1. Introduction The use of radicals or photoactivatable radical precursors has become ubiquitous in the fields of medicinal chemistry and chemical biology in the past three decades.
    [Show full text]
  • In the Search for New Anticancer Drugs, III+ Phosphorylated Diaziridine Derivatives
    In the Search for New Anticancer Drugs, III+ Phosphorylated Diaziridine Derivatives George Sosnovsky* and Jan Lukszo Department of Chemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201, U.S.A. Z. Naturforsch. 38b, 884-894 (1983); received August 30/December 24, 1982 Phosphorylated Diaziridines, Synthesis, Anticancer Drugs, Leukemia P 388 Several N-diethoxyphosphoryl derivatives 7 of various diaziridines, and compounds 12, 15a, lob, 18 and 20, structurally related to TEPA (la) and spin labeled Thio-TEPA (lc) were synthesized. 0 Me 0 N-P(0Et)2 HC=NN-p(<]) o / NR ' • 11 f / 1 ? R-O-P-f N —C—R R X N—R CL N "2 Me Me 1 3 1 2 3 7: R . R = alkyl 12 15a: R = R =R =Me N-0 R2=H, alkyl 15b: R' = H,R2R3=-|CH2|5- Me Me In three cases, attempts to synthesize phosphorylated diaziridine derivatives resulted in rearrangements to give the corresponding phosphorylated hydrazone derivatives 11 h, Hi and 12. Me 0 CH = NN — P(0Et)j 11 h: x= H 11 i : x = ci 13C NMR spectroscopy was shown to be a valuable tool in distinguishing between the structures of diaziridine and hydrazone derivatives. The in vivo testing of five representa- tive compounds (7e, 12, 15a, 16 and 20) against murine lymphocytic leukemia P 388 showed a lack of antitumor activity of compounds 7e, 15 a, 16 and 20, and an activity of compound 12 as evidenced by a T/C value of 194 and a % ILS of 94, at a dose of 32 mg/kg. Introduction pounds, triethylenimine thiophosphoramide, Thio- In the past three decades, extensive studies [1-9] TEPA (lb, R = ethylenimine ring), has been used have been made in the search for new antineoplastic drugs containing the ethylenimine-(aziridine) moi- X ety.
    [Show full text]
  • United States Patent (19) (11) 4,056,469 Eichenhofer Et Al
    United States Patent (19) (11) 4,056,469 Eichenhofer et al. 45) Nov. 1, 1977 (54) PURIFICATION OF WASTE WATER FROM (56) References Cited HYDRAZINE PRODUCTION U.S. PATENT DOCUMENTS 75 Inventors: Kurt-Wilhelm Eichenhofer, 3,767,572 10/1973 Bober et al. ........................... 210/62 Leverkusen; Reinhard Schliebs, 3,923,648 12/1975 Lashley .................................. 210/59 Cologne, both of Germany Primary Examiner-Thomas G. Wyse Attorney, Agent, or Firm-Burgess, Dinklage & Sprung (73) Assignee: Bayer Aktiengesellschaft, (57) ABSTRACT Leverkusen, Germany A process for the purification of waste water produced in hydrazine production by the oxidation of ammonia or (21) Appl. No.: 696,253 an amine with an oxidizing agent in the presence of an aldehyde or ketone, comprising intensively mixing the 22) Filed: June 15, 1976 . waste water with chlorine or a hypochlorite at a tem perature of about 10°C to 110° C and a pH of about 5 (30) Foreign Application Priority Data to 10 until the treated waste water reaches a redox July 3, 1975 Germany ............................. 2529647 potential to platinum, relative to Ag/AgCl, of about -400 mV to +800 mV. Advantageously a small (51) Int. C.’................................................ CO2C5/04 amount of waste water is distilled off both before and (52) U.S. C. ................ ..................... 210/62 after the chlorine or hypochlorite treatment. (58) Field of Search ............................. 210/50, 59, 62; 260/DIG. 2; 423/407,408 9 Claims, 1 Drawing Figure 4,056,469 1. 2 tion at the acid pH of approximately 1.5 necessary when PURIFICATION OF WASTE WATER FROM using sodium chlorite, represents a greater consumption HYDRAZINE PRODUCTION of acid and base.
    [Show full text]
  • Photochemistry of 5-Membered Heteroaryl(Trifluoromethyl)Carbenes In
    University of Nevada, Reno “Photochemistry of 5-Membered Heteroaryl(trifluoromethyl)carbenes in Low Temperature Matrices” A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemistry by Rajendra Ghimire Dr. Robert S. Sheridan/Dissertation Advisor December, 2012 THE GRADUATE SCHOOL We recommend that the dissertation prepared under our supervision by RAJENDRA GHIMIRE entitled Photochemistry of 5-Membered Heteroaryl(trifluoromethyl)carbenes in Low Temperature Matrices be accepted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Robert S. Sheridan, Ph.D., Advisor Vincent J. Catalano, Ph.D., Committee Member Benjamin T. King, Ph.D., Committee Member Jonathan Weinstein, Ph.D., Committee Member James H. Trexler, Ph.D., Graduate School Representative Marsha H. Read, Ph. D., Dean, Graduate School December, 2012 i Abstract We have explored the photochemical reactions of 3-benzothienyl(trifluoromethyl)-, 3-N-methyl-indolyl(trifluoromethyl)-, 2-N-methyl-indolyl(trifluoromethyl)-, benzo- thiazolyl(trifluoromethyl)-, and benzoxazolyl(trifluoromethyl)carbenes in low temperature N 2 matrices. The 3-benzothienyl(trifluoromethyl)carbene rearranged to several new reactive intermediates such as bicyclic intermediate, ring expanded carbene and spiro product, which were not observed or characterized before. The 3- benzothienyl(trifluoromethyl)diazirine led us to a new realm of UV-vis transparent diazirines, which behave as normal diazirine photochemically, but have very weak nπ∗ absorptions which are not visible in experimental UV-vis spectra. Also, we were able to synthesize diazirine precursors of both 2- and 3- N-methyl- indolylcarbene and observed and characterized their carbenes spectroscopically. All three carbenes mentioned above are ground state singlets.
    [Show full text]
  • United States Patent Office
    3,445,461 United States Patent Office Patented May 20, 1969 2 3,445,461 and STEROD DAZARINES AND OAZRD NES AND A PROCESS FOR PRODUCING SAME /S Poul Borrevang and Peter Faarup, Copenhagen, Denmark, RN-NR; assignors to Novo Terapeutisk Laboratorium A/S, wherein each of the symbols R and R2 means hydrogen, Copenhagen, Denmark, a Danish company 5 alkyl, cycloalkyl, hydroxyalkyl, aralkyl, aryl or halogen No Drawing. Filed Aug. 5, 1965, Ser. No. 477,602 aryl, R3 means hydrogen or methyl, R4 means hydrogen, Claims priority, application Great Britain, Aug. 12, 1964, methyl, or halogen, R5 means two hydrogen atoms, hy 32,814/64; May 25, 1965, 22,075/65 drogen and methyl, hydrogen and hydroxyl, or a methyl Int. C. C07c 173/10, 167/00 U.S. C. 260-239.5 13 Claims O ene group, and X means CR CH do ABSTRACT OF THE DESCLOSURE --R or C--Rs Derivatives of the pregnane series and of 17,17-lower dialkyl steroids which carry a spiro-diazirine group, a 5 the compounds having, when X means spiro-diaziridine group or substituted spiro-diaziridine C group in the 3-position are disclosed. These compounds (-R, may be prepared by reaction of chloramine in the pres a A13 double bond and no group Rs, while R means ence of ammonia with the corresponding steroid which 20 lower alkyl, preferably methyl or ethyl, whereas when has in the 3-position a carbonyl group, an imino group X is or a group convertible to an imino group under the con ditions of the reaction.
    [Show full text]